Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions.

de Vries, Rory D; van der Heiden, Marieke; Geers, Daryl; Imhof, Celine; van Baarle, Debbie

de Vries, Rory D; van der Heiden, Marieke; Geers, Daryl; Imhof, Celine; van Baarle, Debbie.

de Vries RD; Department Viroscience, Erasmus MC, Rotterdam, Netherlands.
van der Heiden M; Department of Medical Microbiology and Infection Prevention and.
Geers D; Department Viroscience, Erasmus MC, Rotterdam, Netherlands.
Imhof C; Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, Groningen, Netherlands.
van Baarle D; Department of Medical Microbiology and Infection Prevention and.

J Clin Invest ; 131(24)2021 12 15.

Article in English | MEDLINE | ID: covidwho-1666531

Subject(s)

COVID-19; SARS-CoV-2; Adaptive Immunity; Humans; Immunity, Humoral; T-Lymphocytes

Keywords

Adaptive immunity; Immunology; T cells; Virology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Jci155499

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google